Skip to main content
TipRanks
Go Ultimate75% OFF

NKGen Biotech Korea Co., Ltd. (182400) Ownership - Who Owns NKGen Biotech Korea Co., Ltd.?

NKGen Biotech Korea Co., Ltd. (182400) Ownership Overview

  • 0.52% Mutual Funds
  • 0.57% ETFs
  • 98.91% Public Companies and Individual Investors

The ownership structure of NKGen Biotech Korea Co., Ltd. (KR:182400) stock is a mix of institutional, retail, and individual investors. Approximately 1.09% of the company’s stock is owned by Institutional Investors, and 98.91% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue

Top Shareholders

KR:182400 top shareholders
Holder# of SharesType% HoldingValue
Vanguard363,221Institution0.50%―
Vanguard Star Funds177,790Institution0.25%―
Vanguard Tax-managed Funds107,914Institution0.15%―
Vanguard International Equity Index Funds73,363Institution0.10%―
State Street45,916Institution0.06%―
State Street Institutional Investment Trust18,462Institution0.03%―
Spdr3,802Institution<0.01%―
Hsbc1,277Institution<0.01%―
Invesco154Institution<0.01%―

Top Mutual Fund Holders

KR:182400 top mutual fund holders
Holder# of SharesType% HoldingValue
Vanguard Star Funds177,790Institution0.25%―
Vanguard Tax-managed Funds107,914Institution0.15%―
Vanguard International Equity Index Funds73,363Institution0.10%―
State Street Institutional Investment Trust18,462Institution0.03%―

Top ETF Holders

KR:182400 top ETF holders
Holder# of SharesType% HoldingValue
Vanguard Total International Stock ETF, VXUS ETF177,790Institution0.25%1,278,494
Vanguard FTSE Developed Markets ETF, VEA ETF107,914Institution0.15%776,014
Vanguard FTSE All-World ex-US Small-Cap ETF, VSS ETF49,027Institution0.07%347,554
SPDR S&P International Small Cap ETF, GWX ETF39,090Institution0.05%14,776
Vanguard FTSE Pacific ETF, VPL ETF15,367Institution0.02%110,505
Vanguard Total World Stock ETF, VT ETF8,969Institution0.01%64,496
SPDR Portfolio MSCI Global Stock Market ETF, SPGM ETF6,826Institution<0.01%2,580
SPDR EM Sma Cap Accum.Shs Exchage Traded Fund USD, GB:EMSM ETF3,116Institution<0.01%5,595
Vanguard ESG International Stock ETF, VSGX ETF2,034Institution<0.01%5,585
Vanguard exNA Idx Un, TSE:VIU ETF1,870Institution<0.01%18,175

FAQ

What percentage of NKGen Biotech Korea Co., Ltd. (KR:182400) stock is held by institutional investors?
According to the latest TipRanks data, approximately 1.09% of NKGen Biotech Korea Co., Ltd. (KR:182400) stock is held by institutional investors: 0.52% by mutual funds and 0.57% by ETFs.
What percentage of NKGen Biotech Korea Co., Ltd. (KR:182400) stock is held by retail investors?
According to the latest TipRanks data, approximately 98.91% of NKGen Biotech Korea Co., Ltd. (KR:182400) stock is held by public companies and individual investors.
Who owns the most shares of NKGen Biotech Korea Co., Ltd. (KR:182400)?
Vanguard owns the most shares of NKGen Biotech Korea Co., Ltd. (KR:182400).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.